Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.32	44.51	27.17	20.29	28.02	16.5
Cash & Short-Term Investments	60.32	44.51	27.17	20.29	28.02	16.5
Cash Growth	117.51%	63.80%	33.93%	-27.59%	69.84%	-11.36%
Accounts Receivable	9.66	7.77	5.23	8.48	5.23	2.69
Other Receivables	0.6	0.9	-	-	-	-
Receivables	10.26	8.67	5.23	8.48	5.23	2.69
Inventory	14.41	9.19	14.53	14.68	13.6	11.68
Prepaid Expenses	1.54	1.58	2.45	2.97	1.86	1.15
Restricted Cash	0.15	0.15	0.15	0.15	0.2	0.2
Total Current Assets	86.68	64.1	49.53	46.57	48.91	32.22
Property, Plant & Equipment	4.16	3.45	4.54	6.32	7.36	4.43
Other Intangible Assets	0.28	0.36	0.51	0.67	0.86	1.08
Other Long-Term Assets	0.41	0.37	0.38	0.5	0.72	0.63
Total Assets	91.53	68.28	54.96	54.06	57.84	38.36
Accounts Payable	13.68	8.53	10.23	9.68	10.42	9.45
Accrued Expenses	7.38	7.82	9.49	7.34	6.48	6.13
Current Portion of Leases	0.96	0.99	0.7	0.7	0.55	0.62
Current Unearned Revenue	0.3	0.61	0.2	0.16	0.16	0.28
Total Current Liabilities	22.33	17.95	20.62	17.87	17.61	16.48
Long-Term Leases	2.33	1.66	2.58	3.56	4.15	1.02
Long-Term Unearned Revenue	2.67	2.58	3.31	3.96	4.35	4.44
Total Liabilities	27.33	22.18	26.51	25.39	26.11	21.93
Common Stock	0.08	0.08	0.08	0.07	0.07	0.06
Additional Paid-In Capital	237.36	227.93	218.85	214.09	200.61	158.19
Retained Earnings	-173.24	-181.91	-190.46	-185.49	-168.95	-141.83
Comprehensive Income & Other	-0	-0	-0	-0	-0	-0
Shareholders' Equity	64.2	46.09	28.46	28.67	31.73	16.42
Total Liabilities & Equity	91.53	68.28	54.96	54.06	57.84	38.36
Total Debt	3.29	2.65	3.28	4.26	4.7	1.64
Net Cash (Debt)	57.03	41.86	23.9	16.03	23.32	14.86
Net Cash Growth	131.74%	75.16%	49.05%	-31.24%	56.91%	-12.04%
Net Cash Per Share	0.69	0.54	0.32	0.23	0.35	0.24
Filing Date Shares Outstanding	79.92	77.92	75.48	75.02	68.49	66.92
Total Common Shares Outstanding	79.75	77.5	75.15	74.75	68.31	62.06
Working Capital	64.35	46.15	28.91	28.7	31.29	15.74
Book Value Per Share	0.80	0.59	0.38	0.38	0.46	0.26
Tangible Book Value	63.91	45.74	27.95	28	30.87	15.34
Tangible Book Value Per Share	0.80	0.59	0.37	0.37	0.45	0.25
Machinery	-	3.97	4.26	4.05	4.3	3.92
Construction In Progress	-	0.09	0.01	0.17	0.09	0
Leasehold Improvements	-	2.21	2.15	2.06	2.39	2.36

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q